The success of DOORwaY90 has led to the recently expanded approval of SIR-Spheres for primary HCC. Medscape Medical News
We scan the top radiology sources so you don’t have to.
From AI breakthroughs to imaging trends, we serve up real-time radiology insights.
-
Lower-Dose RT Effective in Aggressive Lymphomas
New findings support a shift away from the long-standing 30-Gy standard established before rituximab and PET response assessment. Medscape Medical News
-
LAIs Tied to Lower Relapse, Mortality Risk in Schizophrenia
Long-acting injectable antipsychotics are linked to a lower risk for disease relapse and mortality than oral antipsychotics in adults with schizophrenia, a new study shows. Medscape Medical News
-
Initial Immune Response Tied to Radiosensitivity in TNBC
In triple-negative breast cancer, initially immune-enriched tumors with residual disease after neoadjuvant therapy may be more resistant to radiotherapy. Medscape Medical News
-
Increase in Physicians Walking Away From Clinical Practice
The proportion of physicians leaving clinical practice has increased since 2013. Medscape Medical News
-
How Semaglutide Led to Severe Reflux Esophagitis in a Woman
A 70-year-old woman developed severe reflux oesophagitis and ulceration after months of semaglutide use, highlighting the potential gastrointestinal risks. Medscape News UK
-
Pancreatic Cancer: Who Should Get Screened?
Pancreatic cancer is one of the deadliest cancers because it is usually detected late. But screening is available. Grace Kim, MD, shares advice on who should be tested. Medscape Gastroenterology
-
Advanced MRI Marker May Predict Diabetic Foot Ulcer Healing
Can MRI spot diabetic foot ulcers that won’t heal? Early data suggest MRI-based microvascular metrics might flag high‑risk wounds, offering further insight to help guide treatment. Medscape Diabetes & Endocrinology
-
Implementing Treat-to-Target Care in Ulcerative Colitis
Dr Jami Kinnucan discusses STRIDE-II guidance for treat-to-target strategies in ulcerative colitis treatment. Medscape Gastroenterology
-
Is It Reasonable to Treat Asymptomatic Severe AS in 2025?
A moderated debate between John Mandrola and EARLY TAVR investigator David Cohen on the early treatment of patients with asymptomatic severe aortic stenosis. theheart.org on Medscape